Coronavirus plasma study shows ‘robust evidence’ of transfusion treatment improving survivability, authors say
In a new study of convalescent plasma transfusions in 20,000 coronavirus patients, authors say the data offers “robust evidence” the treatment is safe and associated with improved survival. The idea behind the therapy is that plasma of recently infected recovered coronavirus patients has antiviral antibodies that can be used to treat other patients with the virus. “Convalescent plasma has… Read More »
